<?xml version="1.0" encoding="UTF-8"?>
<p>Ad5-nCoV is a novel vaccine, developed by genetic engineering with the replication of type 5 adenovirus as a vector of immunity against the protein of the new CoV (
 <xref rid="B96" ref-type="bibr">96</xref>).
</p>
